SamaCare partners with AmerisourceBergen to offer prior authorization platform to specialty practices

Article

The partnership will offer specialty physician practices across retina and other specialties access to SamaCare's platform.

SamaCare, a prior authorization platform for physician-administered medications, today announced a partnership with AmerisourceBergen Specialty GPOs to offer specialty physician practices across retina. (Image courtesy of Adobe Stock/Kadmy)

SamaCare, a prior authorization platform for physician-administered medications, today announced a partnership with AmerisourceBergen Specialty GPOs to offer specialty physician practices across retina. (Image courtesy of Adobe Stock/Kadmy)

SamaCare, a prior authorization platform for physician-administered medications, today announced a partnership with AmerisourceBergen Specialty GPOs to offer specialty physician practices across retina, rheumatology, oncology and neurology access to SamaCare's platform.

According to a news release, SamaCare's workflow automation platform helps specialty practices streamline administrative processes such as specialty drug prior authorizations.

“AmerisourceBergen aims to provide our practices with the latest technologies to enhance care delivery, improve care coordination or augment with new revenue streams,” Charles Deckers, vice president, Business Development and Alliances at AmerisourceBergen, said in the news release. "SamaCare enables providers to unify, digitize, and automate the prior authorization process. In addition to reducing administrative overhead and improving authorization outcomes, SamaCare makes prior authorizations more predictable for specialty practices – with anticipated benefits for revenue cycle management and patient satisfaction."

Moreover, the news release noted nearly 8000 providers and some of the largest pharmaceutical manufacturers in the world utilize SamaCare's platform to unify submission, tracking, and management of prior authorizations across all payers and plans for buy-and-bill medications.

"Collaborating with AmerisourceBergen solidifies our position as the market leader in prior authorization management for medical benefits," Syam Palakurthy, CEO and co-founder of SamaCare, said in the news release. "This strategic partnership further empowers us to realize our mission of making life-changing treatments available to patients at the moment they need them."

According to the news release, on average, practices using SamaCare's platform for prior authorization management and benefit verification see:

  • 67% faster prior authorization resolution time
  • 6-10X reduction in staff time spent per prior authorization
  • 18% higher first-time approval rate on prior authorizations

SamaCare helps pharmaceutical companies, providers, and other stakeholders get life-changing therapies to patients who need them. It provides a free workflow automation platform for medical practices to streamline administrative processes such as specialty drug prior authorizations.

AmerisourceBergen is a global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. It partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.